Lexicon Pharmaceuticals/ US5288723027 /
| 2024-05-10 9:59:58 PM | Chg. -0.10 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 1.79USD | -5.04% | 60,202 Turnover: 107,963.22 |
-Bid Size: - | -Ask Size: - | 1.89 | 1.75 |
GlobeNewswire
05-09
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
GlobeNewswire
05-02
Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
04-29
Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals
GlobeNewswire
04-29
Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on ...
GlobeNewswire
04-03
Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire
03-25
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Spon...
GlobeNewswire
03-12
New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotaglif...
GlobeNewswire
03-11
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
03-11
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
GlobeNewswire
03-11
Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA
GlobeNewswire
2023-12-21
Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conference
GlobeNewswire
2023-11-30
Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathi...
GlobeNewswire
2023-11-22
Lexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and th...
GlobeNewswire
2023-11-12
INPEFA® (sotagliflozin) Use Associated With Early Clinical Benefit in Heart Failure and Atherosclero...
GlobeNewswire
2023-11-11
Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American...
GlobeNewswire
2023-11-10
Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
GlobeNewswire
2023-11-08
Lexicon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-11-03
Lexicon Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call and Webcast on ...
GlobeNewswire
2023-11-02
Data on Early Clinical Benefit for INPEFA® (Sotagliflozin) Will Be Among Five Lexicon-Sponsored Pres...
GlobeNewswire
2023-11-01
INPEFA® (Sotagliflozin) Receives Coverage From Express Scripts on Its Basic and High Performance For...
GlobeNewswire
2023-10-30
New Data Relating to Sotagliflozin to be Presented at the American Society of Nephrology (ASN) Kidne...
